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CASE REPORT
Introduction
Beckwith-Wiedemann syndrome (BWS) is charac-
terised by general overgrowth with a variable association
of exomphalos, macroglossia and gigantism triad (EMG)
in association with multiple abnormalities including hemi-
hypertrophy, coarse facies, ear lobe creases and hypogly-
caemia in the newborn infants.1 The development of con-
comitant malignant tumors (Wilms tumor, hepatoblas-
toma, embryonal rhabdomyosarcoma etc.) is relatively
frequent.2,3
BWS is a genetically heterogeneous disorder. Imprinted
genes, located mainly at 11p15.5, like CDKN1C/p57KIP-2
and KvLQT1are supposed to be involved in the etiology of
BWS and its concomitant malignancies.4,5 Acid sphin-
gomyelinase (ASM) catalyses the cleavage of sphin-
We report the association of Beckwith-Wiedemann
syndrome (BWS) and a residual acid sphingomyeli-
nase (ASM) activity of about 35% in a 23 months
old Hungarian boy. Besides the classical triad of
exomphalos, macroglossia and gigantism some
other BWS-related features: polyhydramnios
(known from the praenatal history), hemihypertro-
phy, craniofacial dysmorphy, a mild mental retar-
dation, bilaterally undescended testes, cardiac
anomalies and a terminally developed, fatal embry-
onal rhabdomyosarcoma were present in the
patient. The decreased activity of the ASM was
measured in the patient’s skin fibroblasts. This
result, with hepatomegaly, mental retardation,
feeding problems, a failure to thrive and muscle-
hypotony, partially resembled the ASM-deficient
forms of Niemann-Pick disease (NPD). Morpholog-
ical analysis of the bone-marrow cells gave normal
results. There was no chromosomal alteration
found by conventional karyotyping of the patient’s
lymphocytes.BWS-associated genes as well as the
human ASM gene (SMPD1) are all located at 11p15.
DNA-studies by region specific markers as well as
mutational analysis for the most common NPD-
mutations are planned in the future. This is the first
report on the simultaneous occurrence of BWS and
ASM-deficiency. (Pathology Oncology Research Vol
6, No 4, 295–297, 2000)
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gomyelin to phosphorylcholine and ceramide. A deficien-
cy of sphingomyelinase have been demonstrated in the 
A- and B- forms of the Niemann-Pick group of lysosomal
storage disorders (NPD). In the classical A form of the
disease hepatosplenomegaly, severe neurological mani-
festations as well as mental and physical retardation are
usually present. Group B patients remain free of neuro-
logic disturbances despite massive visceral involvement.6
The human ASM gene (SMPD1) has been located at
11p15.4.7 In our case report we describe the concomitant
occurrence of ASM-deficiency and BWS with a embryonal
rhabdomyosarcoma developed terminally.
Case report 
A 23 months old boy, with dysmorphic features and
somatomental delay, was admitted to our department in
order to establish a diagnosis. Similar symptoms had not
occurred in his family before. The boy was born of Hun-
garian parents, from a second, polyhydramnionic preg-
nancy in the 36th. gestational week by Caesarean section,
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after a healthy daughter. His weight at birth was 5170 g.
Up to 6 weeks of age he was treated in a neonatal intensive
care unit with respiratory distress. He was fed through a
gastrostomic tube because of early feeding problems. The
specific deviations in his physical state: gargoyle-like fea-
tures (coarse facies, low-set ears, ear lobe creases, wide-
set, exophthalmic eyes, a high-arched palate and
macroglossia) furthermore macrosomy, abdominal rectus
diastasis, hemihypertrophy, systolic murmur above the
heart and bilateral testis retention) were indicated by early
examinations soon after birth. However, definitive diagno-
sis was not established that time. 
By the time of his admission to our Department (Fig-
ure 1), physical examinations revealed a delay in weight
and height gain; dry skin, a paste-like sensation of the
subcutis by palpation, an open anterior fontanelle (as
large as a finger-pad), a deformed chest, gracile extremi-
ties, hyperextensibility of all joints, hypotonic muscles
and umbilical hernia, besides the above mentioned sym-
poms. When raised he was able to remain in sitting posi-
tion. When put on his feet he was able to toddle with
external help. He could observe his surroundings and he
gurgled. He was able to understand simple requests and
carry them out. 
Clinical examination 
Fasting blood glucose test, renal and liver function tests,
abdominal ultrasound* and ophthalmological investiga-
tions (control of fundus and ocular pressure) all gave nor-
mal results. Cytogenetic analysis of the patient’s lympho-
cytes revealed a normal karyotype. Brain ultrasound
showed slightly widened ventricles and persisting cavum
septum pellucidum. Brain CT and MRI showed cortical
atrophy. Besides VEP-alterations, EEG and BAEP gave
normal results. Echocardiography revealed small, AV type
VSD, with slight mitral insufficiency. EMG raised the
possibility of myopathy. Biopsy specimens taken from
skin and muscle were evaluated by both light - and elec-
tron microscopic studies. EM revealed lipoid cells as well
as acrofilamental aggregation in 30% of the muscle fibres.
Wide-ranging metabolic investigations (including serum
and urine metabolites as well as enzyme activities from
skin fibroblast culture) gave normal results. The only
exception was the activity of the acidic sphingomyelinase
enzyme in skin fibroblasts. It was significantly below the
lower edge of the accepted normal range (48 nmol/mg pro-
tein/hr vs. the normal range: 129–143 nmol/mg protein/hr).
A few weeks after his last discharge from the Depart-
ment surgical intervention was necessary because of an
acute ileus. A fist-sized abdominal tumor was removed. At
that time hepatosplenomegaly was noted. 
Histologically the tumor was an embryonal rhab-
domyosarcoma. There were no pathologic cells seen in the
bone -marrow smears.
Clinically the tumor was rapidly growing (development
within a month) with an unusual resistance to chemother-
apy. Despite intensive cytostatic treatment (VP-16, Elo-
bromol) the patient died a few months later. 
Post mortem neurohistological investigations revealed
the lack of neocortex layers V. and VI. Furthermore
ectopic neuronal cells in the medullary substance, gracile
pyramidal tract and a decreased number of the spinal
motoneurons could be observed.
Discussion
BWS has no exactly described diagnostic criteria. The
following guidelines can help in the establishment of the
diagnosis: The presence of the three main features (pre- or
postnatal overgrowth, macroglossia, closure abnormalities
of the anterior abdominal wall) or the presence of two of
the main features and three of the followings: ear lobe
creases, facial naevus flammeus, hypoglycaemia, kidney
enlargement, hemihypertrophy.1
The diagnosis of BWS syndrome in our case has been
supported by the presence of all of the three main features,
as well as by other characteristics like hemihypertrophy,
craniofacial dysmorphy, a mild mental retardation , bilat-
erally undescended testes, cardiac anomalies, a embryonal
rhabdomyosarcoma terminally developed as well as poly-
hydramnios known from the praenatal history. The symp-
toms of RDS after birth, well known from the patient’s
early medical reports, could have been mimicked by a
neonatal hypoglycaemia, hidden at the background. 
Basically, BWS syndrome has to be differentiated from
Simpson-Golabi-Behmel syndrome (SGBS) and Perlman
syndrome (PS).1 In our case SGBS, which is inherited in
an X-recessive mode, could be excluded by the lack of
some characteristic features of this syndrome like normal
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*Hepatomegaly was detected only later.
Figure 1. 
intelligence; bulldog-like face; supernumerary nipples;
broad and short hands with polydactylia etc.8
PS is a rare disorder with an autosomal recessive inheri-
tance. Although high neonatal mortality rate, hypogly-
caemia, renal malformations and the development of Wilms
tumor are symptomatic features, exomphalos and
macroglossia are not characteristic of this syndrome.9 With
respect to further details as well as to other diseases charac-
terised by overgrowth we refer to the scientific literature.10,11
The ASM activity, measured in the skin fibroblasts of
the patient, was about 35% of the average level. This result
as well as other clinical signs like the serious feeding prob-
lems, a failure to thrive, and muscle-hypotony have par-
tially resembled the ASM-deficient forms of NPD.
Hepatosplenomegaly was detected only at the time of the
tumor-development. The involvement of the liver and
spleen may be subtle in mild NPD cases, and therefore its
detection may be delayed into adulthood.6
Overlaps between the clinical symptoms of BWS and
NPD are hard to assess, mainly because of the wide vari-
ety of symptoms in both clinical entities. However, the
clinical appearance of BWS patients sometimes resemble
storage-disorders, with coarse facies, hepatomegaly and
mental retardation. The latter two symptoms are features
of NPD as well.
We have not yet found a clinical description similar to
this among the publications dealing with NPD. Muta-
tional analysis, to be planned in the future, may provide
useful information about the genetic background of these
findings. 
Three distinct BWS-regions on chromosome 11p15
have been identified by Mannens et al,12 by the analysis of
balanced chromosomal BWS-rearrangements. They have
been designated as BWSCR1, at 11p15.5, and as
BWSCR2- and BWSCR3, at 11p15.3. Genes of these
regions may be involved in the development of BWS, pos-
sibly through the control of IGF2 expression.13
Several mutations have been identified in Ashkenazi
Jews as well as in non-Jewish patients with NPD. The
R496L, L302P and fsP330 mutations account for more
than 90 percent of the mutant alleles in Ashkenazic Jewish
patients with NPD-A. DR608 mutation has been described
among Ashkenazic Jewish patients with NPD-B. Its true
frequency is unknown, but it is relatively frequent in
patients from North Africa as well. Other non-Jewish
patients with type A and B NPD have each had unique
mutations.6
The chromosomal localization of the ASM gene
(SMPD1) was refined to a 1 Mb region just distal to
BWSCR2.14 Recently, at the 6th International Workshop on
Human Chromosome 11 Mapping, where this clinical
observation was also presented, SMPD1 was assigned to
11p15.4.7
Stored DNA samples from the patient and from his fam-
ily-members, isolated from peripherial blood, are the only
available sources for further DNA investigation in this
case. Thus, negative results can not exclude mosaic states.
(Explanation of the possible molecular genetic back-
ground is discussed in a hypothesis article in this issue by
Réthy LA.) For the future we propose to screen of known
BWS patients, especially those with translocational break-
points at BWSCR-II region, for ASM-deficiency and/or
SMPD1 mutations.
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